In addition, the reduced VEGF expression was reported in breast cancer models treated with apigenin [59], luteolin [60], soy protein [61] and Kalpaamruthaa [51], as well as a decrease in VEGFR-2 expression treated with apigenin [59] and melatonin [62]. Here, KDR is linked to breast carcinoma.